Articles that mention Novartis -BoardProspects

Novartis

0 Comments Leave a Comment

1-15 of 27 1 2 »
1. Mentioned In 27 Articles
2. 20 Highest-Paid Biopharma CEOs
  
  Explore Pharma News Sep 18 2020 BoardNews
  
  ...($AZN) Pascal Soriot, for instance. GlaxoSmithKline's ($GSK) Andrew Witty. And this year, both Joe Jimenez of Novartis ($NVS) and Severin Schwan of Roche ($RHHBY) fell several million short of the cutoff. Then there's th...
  Read Full Article
  
  Comment
  
  Mentions: Twitter stock options Vertex
3. Gilead Reaches $21 Billion Deal for Immunomedics
  
  Explore MarketWatch Sep 13 2020 BoardNews
  
  ...e moved to establish beachheads in cancer treatment, creating a heavily contested battleground with stalwarts Novartis AG and Roche Holding AG. The desirability of cancer treatments, especially those like Trodelvy that h...
  Read Full Article
  
  Comment
  
  Mentions: acquisition stake Gilead Sciences
4. Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors
  
  Explore GlobeNewswire Aug 4 2020 BoardMoves
  
  ...and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and four development-stage product candidates...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Investor Relations Investment
5. Protara Therapeutics Announces Appointment of Barry P. Flannelly to Board of Directors
  
  Explore biospace.com Jul 24 2020 BoardMoves
  
  ... held roles of increasing responsibility in medical affairs, strategic planning, and commercial operations at Novartis Pharmaceuticals Corporation, Abraxis Oncology, Onyx Pharmaceuticals, Inc., and Nektar Therapeutics. T...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi Nasdaq University of Maryland
6. Coronavirus Treatments - If More Women Are On The Board, It’s Likely Safer, New Study Finds
  
  Explore forbes.com May 9 2020 BoardBlogs
  
  ... issued a warning about in an editorial. The company developing this highly controversial COVID-19 treatment, Novartis, has four women on their board of 14 members. It includes at least two formidable women who one would...
  Read Full Article
  
  Comment
  
  Mentions: Women Female culture
7. Vasomune Therapeutics Appoints Meenu Chhabra to its Board of Directors
  
  Explore businesswire.com Mar 24 2020 BoardMoves
  
  ...he served as Vice President of Business Development and Licensing at the Novartis Pharmaceuticals division of Novartis AG (NYSE: NVS). From July 2003 to November 2006, she served as Chief Business Officer at BioXell SpA,...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Bristol-Myers Squibb NYSE
8. Model N Welcomes Kimberly DeCarlis as New Board Member
  
  Explore businesswire.com Jan 15 2020 BoardMoves
  
  ...ductor, and high-tech manufacturing across more than 120 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com....
  Read Full Article
  
  Comment
  
  Mentions: Chief Marketing Officer NYSE Stanford University
9. W2O Appoints Biopharma and Digital Marketing Leaders Jonathan Peacock and George Gallate to Board of Directors ...
  
  Explore businesswire.com Dec 4 2019 BoardMoves
  
  ...Peacock’s tenure at Amgen, the company’s share price increased by approximately 125%. While serving as CFO at Novartis Pharma, he helped increase the company’s operating profit by 40%. From 2014 to 2017, he served as Aud...
  Read Full Article
  
  Comment
  
  Mentions: Google Amazon Twitter
10. Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.
  
  Explore The New York Times Aug 8 2019 BoardNews
  
  ...ponding to the agencys stern rebuke, Vas Narasimhan, the companys executive, tried to reassure investors that Novartis did not intentionally deceive the F.D.A. while seeking approval for its $2.1 million gene therapy ......
  Read Full Article
  
  Comment
  
  Mentions: Novartis Vas Narasimhan Investors
11. American Express Company: Strong Shareholder Rights And Aligned Management Incentives
  
  Explore Stock Market News & Financial Analysis Aug 7 2019 BoardBlogs
  
  ...e is led by Daniel L. Vasella who is the honorary Chairman and former Chairman and Chief Executive Officer of Novartis AG (NVS). He has deep experience in operating a highly regulated global business complicated by inves...
  Read Full Article
  
  Comment
  
  Mentions: Management Vanguard acquisition
12. Progenics to Mail Letter to Shareholders
  
  Explore Stock Market Data Today Jun 19 2019 BoardNews
  
  ...with significant experience in commercial-stage oncology products. For example, Michael Kishbauch established Novartis’ Oncology Field Force, helping to launch its first product, Aredia (pamidronate), and paving the way ...
  Read Full Article
  
  Comment
  
  Mentions: Governance Committee Annual Meeting Nasdaq
13. UBiome's Independent Directors are Ditching the Healthcare Startup Following an FBI Raid
  
  Explore Business Insider May 15 2019 BoardNews
  
  ...Apte on administrative leave. John Rakow the company's general counsel, is serving as the interim CEO. Former Novartis CEO Joe Jimenez had been on UBiome's board as well, but resigned earlier in April prior to the FBI ra...
  Read Full Article
  
  Comment
  
  Mentions: Independent Director Special Committee resign
14. Aspen Technology Appoints Georgia Keresty PhD, MPH to Its Board of Directors
  
  Explore businesswire.com Apr 18 2019 BoardMoves
  
  ...ovation. During a career that includes executive roles at Takeda, Johnson & Johnson, Bristol Myers Squibb and Novartis, Keresty has been responsible for operations in more than 20 countries and led a $150M R&D affiliate ...
  Read Full Article
  
  Comment
  
  Mentions: Leadership Management Independent Director
15. AbbVie Investors Agitate for Chair-CEO Split, Flagging Bonus Pay and Humira Hikes
  
  Explore Pharma News Apr 2 2019 BoardNews
  
  ...er those patents hoping to launch its biosim, Cyltezo, before its rivals do. Top biosimilar makers, including Novartis' Sandoz unit and Mylan, have settled their own Humira patent fights with deals that put off launches ...
  Read Full Article
  
  Comment
  
  Mentions: Mylan lawsuit Allergan
16. Novartis Faces Questions About Proxy Voting Independence
  
  Explore Front Page Mar 27 2019 BoardNews
  
  ...via GPS trackers and found that they were diverted and sent to Novartis headquarters instead. This means that Novartis can see the name of shareholders and their voting positions ahead of the shareholder meeting, indicat...
  Read Full Article
  
  Comment
  
  Mentions: investigation independence Novartis
17. 1-15 of 27 1 2 »